Back

Long term shock efficacy of the subcutaneous defibrillator in the EFFORTLESS extension sub study

31 August 2026 (12:50 - 13:00)
Organised by: Logo
Congress Presentation Part of: Latest developments in device-based cardiac therapy Cardioversion and Defibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Pier Lambiase

Barts Heart Centre, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Jugular versus femoral access for leadless pacemaker implantation: a propensity score–matched multicenter analysis
Doctor R. De Lucia (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Left ventricular endocardial pacing via controlled interventricular septal lead passage as bailout after failed left bundle branch area pacing optimized CRT
Assistant Professor O. Iatsenko (Odessa, UA)
Abstract Slides Video
Presentation thumbnail
Machine learning can detect left bundle branch area capture from individual-beat lead-restricted ECGs
Doctor A. Naraen (London, GB)
Abstract Slides Video
Presentation thumbnail
Impact of increased plasma potassium levels on biventricular pacing: a prespecified analysis from a randomised clinical trial (POTCAST)
Miss E. Danielsen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Comparative electrophysiology of aortic root pacing in humans
Professor I. Karpenko (Odessa, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Latest developments in device-based cardiac therapy
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 12:50 CET
You may be interested in
thumbnail
Congress Session
Latest science in ICD and sudden cardiac death
28 August 2022
thumbnail
Congress Presentation
Long-term incidence and efficacy of appropriate therapy in subcutaneous and transvenous implantable cardioverter-defibrillators: A secondary analysis of the PRAETORIAN-XL trial
29 August 2026
thumbnail
Congress Presentation
Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator
3 April 2022
thumbnail
Congress Presentation
Extravascular implantable cardioverter-defibrillator: from trial evidence to real-world and single-center experience
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources